Omadacycline: Clinical trial data

Pooled data from the intent-to-treat (ITT) population of 359 patients with CSSSIs who were enrolled in either a double-blind, U.S. Phase II or a double-blind, U.S. Phase III trial

Read the full 296 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE